SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-19-010591
Filing Date
2019-05-21
Accepted
2019-05-21 16:50:49
Documents
4
Period of Report
2019-05-16
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nby20190516_8k.htm 8-K 21017
2 EXHIBIT 99.1 ex_145497.htm EX-99.1 10575
3 ex_145497img001.jpg GRAPHIC 15639
4 logo01.jpg GRAPHIC 9343
  Complete submission text file 0001437749-19-010591.txt   67418
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33678 | Film No.: 19843001
SIC: 2834 Pharmaceutical Preparations